Comparing effectiveness of prognostic tests in idiopathic pulmonary fibrosis
Sign Up to like & getrecommendations! Published in 2019 at "Expert Review of Respiratory Medicine"
DOI: 10.1080/17476348.2019.1656069
Abstract: ABSTRACT Introduction: Idiopathic pulmonary fibrosis (IPF) is a debilitating and progressive fibrotic interstitial lung disease often resulting in death over several years. Prediction of disease course or survival remains of keen interest for clinicians and… read more here.
Keywords: idiopathic pulmonary; effectiveness prognostic; prognostic tests; comparing effectiveness ... See more keywords
Abstract 5411: Efficient development of prognostic tests for detecting cancer risk using proteomic technology
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-5411
Abstract: Background: Prognostic models for assessing future health outcomes can be developed using time-to-event (also known as “survival”) data. This methodology is ubiquitous in statistical literature and in the analysis of cancer outcomes, but its use… read more here.
Keywords: methodology; development; risk; cancer risk ... See more keywords
Survival and prognostic tests in a real-world phase II experience with a safe, moderate-dose, sequential chemotherapy (CT) algorithm (ALGO) for metastatic pancreatic adenocarcinoma (PANC).
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.e16763
Abstract: e16763Background: Gemcitabine (G), 5-fluorouracil (F), leucovorin (L), irinotecan (I), and oxaliplatin (O), (GFLIO) is safe, employs moderate 1/2-1/3 dosages, offers expanded eligibility (0-2 ECOG ... read more here.
Keywords: survival prognostic; real world; tests real; prognostic tests ... See more keywords